Susan M. Ott
#148,921
Most Influential Person Now
Susan M. Ott's AcademicInfluence.com Rankings
Susan M. Ottphilosophy Degrees
Philosophy
#8142
World Rank
#11468
Historical Rank
Logic
#5172
World Rank
#6548
Historical Rank
Susan M. Ottbiology Degrees
Biology
#10996
World Rank
#14366
Historical Rank
Physiology
#349
World Rank
#564
Historical Rank
Download Badge
Philosophy Biology
Susan M. Ott's Degrees
- Doctorate Medicine University of Washington
- PhD Physiology University of Washington
Why Is Susan M. Ott Influential?
(Suggest an Edit or Addition)Susan M. Ott's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Bone histomorphometry: Standardization of nomenclature, symbols, and units: Report of the asbmr histomorphometry nomenclature committee (1987) (5046)
- Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures (1996) (3767)
- Standardized nomenclature, symbols, and units for bone histomorphometry: A 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee (2013) (1974)
- Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). (2006) (1734)
- Change in Bone Turnover and Hip, Non‐Spine, and Vertebral Fracture in Alendronate‐Treated Women: The Fracture Intervention Trial (2004) (387)
- Incidence of atypical nontraumatic diaphyseal fractures of the femur (2012) (378)
- Bone mineral density after resumption of menses in amenorrheic athletes. (1986) (358)
- The prevalence of bone aluminum deposition in renal osteodystrophy and its relation to the response to calcitriol therapy. (1982) (343)
- Calcitriol treatment is not effective in postmenopausal osteoporosis. (1989) (293)
- Relationships between mandibular and skeletal bone in an osteoporotic population. (1989) (284)
- Bone aluminum and histomorphometric features of renal osteodystrophy. (1982) (279)
- Histological quantitation of aluminum in iliac bone from patients with renal failure. (1982) (258)
- Long-term safety of bisphosphonates. (2005) (227)
- Aluminum is associated with low bone formation in patients receiving chronic parenteral nutrition. (1983) (216)
- Change in bone mineral density among adolescent women using and discontinuing depot medroxyprogesterone acetate contraception. (2005) (213)
- Osteoporosis in chronic kidney disease. (2004) (195)
- Low-Dose Hydrochlorothiazide and Preservation of Bone Mineral Density in Older Adults (2000) (192)
- Relationships between mandibular and skeletal bone in a population of normal women. (1990) (183)
- Ability of four different techniques of measuring bone mass to diagnose vertebral fractures in postmenopausal women (1987) (177)
- Injectable Hormone Contraception and Bone Density: Results from a Prospective Study (2002) (173)
- Editorial: Attainment of Peak Bone Mass (1990) (156)
- Use of the deferoxamine infusion test in the diagnosis of aluminum-related osteodystrophy. (1984) (153)
- Effect of parathyroidectomy on bone aluminum accumulation in chronic renal failure. (1985) (142)
- Mineral Changes in Osteoporosis: A Review (2006) (141)
- Bone mineral density in women using depot medroxyprogesterone acetate for contraception. (1999) (140)
- Histopathological assessment of prostate cancer bone osteoblastic metastases. (2008) (133)
- Bone Histomorphometric and Biochemical Marker Results of a 2‐Year Placebo‐Controlled Trial of Raloxifene in Postmenopausal Women (2002) (108)
- Contribution of raloxifene and calcium and vitamin D3 supplementation to the increase of the degree of mineralization of bone in postmenopausal women. (2003) (107)
- Cortical or Trabecular Bone: What’s the Difference? (2018) (106)
- Bone Mineral, Histomorphometry, and Body Composition in Adults with Growth Hormone Receptor Deficiency (1998) (105)
- Bone density loss after allogeneic hematopoietic stem cell transplantation: a prospective study. (2001) (104)
- Bone Structure in Patients with Low Bone Mineral Density With or Without Vertebral Fractures (2000) (101)
- Sclerostin and Wnt signaling--the pathway to bone strength. (2005) (92)
- Bone histology at autopsy and matched bone scintigraphy findings in patients with hormone refractory prostate cancer: The effect of bisphosphonate therapy on bone scintigraphy results (2004) (92)
- Special concerns of the female athlete. (2004) (91)
- The effects of pregnancy on the musculoskeletal system. (2000) (90)
- Metabolic bone disease of total parenteral nutrition: course after changing from casein to amino acids in parenteral solutions with reduced aluminum content. (1988) (90)
- Skeletal status of men with early and late ankylosing spondylitis. (1997) (87)
- Osteoporosis in patients with cystic fibrosis. (1998) (86)
- Effects of contraceptive use on bone biochemical markers in young women. (2001) (83)
- Bone density in adolescents. (1991) (77)
- Attainment of peak bone mass. (1990) (71)
- Aluminum as a factor in the bone disease of long-term parenteral nutrition. (1982) (71)
- Cystatin‐C, Renal Function, and Incidence of Hip Fracture in Postmenopausal Women (2008) (70)
- Association of atypical femoral fractures with bisphosphonate use by patients with varus hip geometry. (2014) (69)
- Depressive symptoms in users and non-users of depot medroxyprogesterone acetate. (2000) (69)
- Histomorphometric measurements of bone turnover, mineralization, and volume. (2008) (66)
- Oral contraceptive use and bone density in adolescent and young adult women. (2010) (65)
- Longitudinal changes in bone density in relation to oral contraceptive use. (2003) (62)
- Comparisons among methods of measuring bone mass and relationship to severity of vertebral fractures in osteoporosis. (1988) (62)
- What is the optimal duration of bisphosphonate therapy? (2011) (61)
- Indirect methods for the diagnosis of aluminum bone disease: plasma aluminum, the desferrioxamine infusion test, and serum iPTH. (1986) (60)
- When bone mass fails to predict bone failure (2005) (58)
- Healing of reamed glenoid bone articulating with a metal humeral hemiarthroplasty: A canine model (2005) (58)
- Fractures after long-term alendronate therapy. (2001) (57)
- Review article: Bone density in patients with chronic kidney disease stages 4‐5 (2009) (57)
- The association between depot medroxyprogesterone acetate contraception and bone mineral density in adolescent women. (2004) (56)
- Should women get screening bone mass measurements? (1986) (54)
- Bone histomorphometric changes after cyclic therapy with phosphate and etidronate disodium in women with postmenopausal osteoporosis. (1994) (52)
- Comparison of outcomes between males and females after anterior cruciate ligament reconstruction (2003) (48)
- Faculty Opinions recommendation of A translocation causing increased alpha-klotho level results in hypophosphatemic rickets and hyperparathyroidism. (2008) (48)
- Is protein intake associated with bone mineral density in young women? (2010) (47)
- Oral contraceptive use and bone density change in adolescent and young adult women: a prospective study of age, hormone dose, and discontinuation. (2011) (47)
- Metabolic bone disease in adults receiving long-term parenteral nutrition: longitudinal study with regional densitometry and bone biopsy. (1993) (45)
- Histological, immunophenotypic and histomorphometric characterization of prostate cancer bone metastases. (2004) (45)
- Bone histologic response to deferoxamine in aluminum-related bone disease. (1987) (43)
- Heterogeneity of bone histology in parenteral nutrition patients. (1987) (43)
- Mineral loss in the parenteral nutrition patient. (1988) (42)
- Development and reversibility of aluminum-induced bone lesion in the rat. (1987) (41)
- Evaluation of vertebral volumetric vs. areal bone mineral density during growth. (1997) (39)
- Bone histomorphometry in renal osteodystrophy. (2009) (38)
- Bone Physiology During Pregnancy and Lactation in Young Macaques (1999) (38)
- Clinical effects of bisphosphonates in involutional osteoporosis (1993) (37)
- Therapy for patients with CKD and low bone mineral density (2013) (36)
- Changes in bone histology after treatment with desferrioxamine. (1986) (34)
- Augmenting simplified habit reversal in the treatment of oral-digital habits exhibited by individuals with mental retardation. (1999) (34)
- The effect of raloxifene on bone marrow adipose tissue and bone turnover in postmenopausal women with osteoporosis. (2017) (32)
- Methods of determining bone mass (1991) (31)
- Effects of three years of low-dose thiazides on mineral metabolism in healthy elderly persons (2008) (31)
- Chapter 1: Introduction and definition of CKD-MBD and the development of the guideline statements. (2009) (30)
- Association between caffeine intake and bone mass among young women: potential effect modification by depot medroxyprogesterone acetate use (2008) (30)
- Bisphosphonate safety and efficacy in chronic kidney disease. (2012) (27)
- Pseudohyperparathyroidism. Syndrome associated with aluminum intoxication in patients with renal failure. (1985) (27)
- A Preliminary Study of Joint Surface Changes After an Intraarticular Fracture: A Sheep Model of a Tibia Fracture With Weight Bearing After Internal Fixation (2001) (27)
- Ethnic differences in bone and mineral metabolism in healthy people and patients with CKD. (2014) (27)
- Osteoporosis in women with spinal cord injuries. (2001) (27)
- Bisphosphonates as a risk factor for adverse orthodontic outcomes: a retrospective cohort study. (2012) (27)
- Bone strength: more than just bone density. (2016) (26)
- Total body calcium by neutron activation analysis in normals and osteoporotic populations: a discriminator of significant bone mass loss. (1983) (23)
- D-lactate and metabolic bone disease in patients receiving long-term parenteral nutrition. (1989) (23)
- Histomorphometric Analysis of Bone Remodeling (2002) (23)
- Bone Health Management After Hematopoietic Cell Transplantation: An Expert Panel Opinion from the American Society for Transplantation and Cellular Therapy. (2020) (21)
- Aluminum accumulation in individuals with normal renal function. (1985) (20)
- Pharmacokinetics of oral micronized beta-estradiol in postmenopausal women receiving maintenance hemodialysis. (2003) (19)
- Bone disease in CKD (2012) (19)
- Calcimimetics--new drugs with the potential to control hyperparathyroidism. (1998) (18)
- Sensitivity and specificity of radiographic characteristics in atypical femoral fractures (2016) (18)
- Atypical femur fracture incidence in women increases with duration of bisphosphonate exposure (2019) (17)
- Bone oxalate in a long-term hemodialysis patient who ingested high doses of vitamin C. (1986) (17)
- Parathyroid hormone in aluminum bone disease: a comparison of parathyroid hormone assays. (1986) (17)
- Aluminum - related osteomalacia. (1983) (17)
- Pharmacology of Bisphosphonates in Patients with Chronic Kidney Disease (2015) (17)
- Renal Osteodystrophy—Time for Common Nomenclature (2017) (17)
- Utility of automated data in identifying femoral shaft and subtrochanteric (diaphyseal) fractures (2011) (16)
- Bone mass measurements: reasons to be cautious (1994) (15)
- Role of Aluminum Accumulation in Renal Osteodystrophy (1984) (15)
- Effect of Low‐Dose Thiazide Diuretics on Plasma Lipids: Results from a Double‐Blind, Randomized Clinical Trial in Older Men and Women (2003) (14)
- Atraumatic bilateral femur fracture in long-term bisphosphonate use. (2010) (13)
- Evaluation of bone in dialysis patients exposed to aluminum in dialysate (1982) (12)
- Osteoporosis and Bone Physiology (2013) (12)
- Navel jewelry artifacts and intravertebral variation in spine bone densitometry in adolescents and young women. (2009) (12)
- Bones and the sex hormones. (2018) (11)
- Depot Medroxyprogesterone Acetate in Teens: A Risk for Bone Health? (2000) (11)
- Bone cells, sclerostin, and FGF23: what's bred in the bone will come out in the flesh. (2015) (11)
- Bone formation periods studied with triple tetracycline labels in women with postmenopausal osteoporosis (1993) (11)
- BONE ALUMINIUM AND HISTOMORPHOMETRIC FEA-TURES OF RENAL OSTEODYSTROPHY (1982) (11)
- Hypocalciuria and abnormalities in mineral and skeletal homeostasis in patients with celiac sprue without intestinal symptoms (1997) (10)
- Role of proton receptor OGR1 in bone response to metabolic acidosis? (2016) (10)
- Estrogen therapy for osteoporosis--even in the elderly. (1992) (9)
- Oral contraceptive use and fracture risk around the menopausal transition (2016) (9)
- Diet for the heart or the bone: a biological tradeoff. (2004) (9)
- Importance of bone turnover for therapeutic decisions in patients with CKD-MBD. (2021) (9)
- Vitamin D dose requirements for fracture prevention. (2012) (8)
- Review: Osteoporosis drugs may improve BMD and reduce fractures in some patients with CKD (2017) (8)
- Accuracy of ICD-9 codes to identify nonunion and malunion and developing algorithms to improve case-finding of nonunion and malunion. (2013) (8)
- Longitudinal changes in bone mass after one year as measured by different techniques in patients with osteoporosis (1986) (7)
- Bisphosphonate Treatment Beyond 5 Years and Hip Fracture Risk in Older Women (2020) (7)
- Accuracy of dual photon absorptiometry in excised femurs. (1988) (7)
- The editorialist replies (2012) (7)
- A comparison of self-reported oral contraceptive use and automated pharmacy data in perimenopausal and early postmenopausal women. (2015) (6)
- Sources of aluminum (1990) (6)
- New aspects of normal bone biology (2010) (5)
- Renal Function and Bisphosphonate Safety (2007) (5)
- Reproductive hormones and skeletal health in young women. (2008) (5)
- Long-term bisphosphonates: primum non nocere. (2016) (5)
- Use of alendronate after 5 years of treatment. (2007) (5)
- CORRELATION BETWEEN FRACTURE INDEX AND BONE DENSITOMETRY BY CT AND DUAL PHOTON ABSORPTIOMETRY (1985) (4)
- Osteoporosis associated with chronic kidney disease (2021) (4)
- Making decisions about hormone replacement therapy: Bisphosphonates should not be recommended for women aged 50 (2003) (4)
- What should be the interval between bone density screenings? (2013) (4)
- Bone Health in Women with Breast Cancer (2006) (4)
- Bone Biology and Effects of Pharmaceutical Intervention on Bone Quality (2017) (4)
- Risk of complete atypical femur fracture with Oral bisphosphonate exposure beyond three years (2020) (3)
- Atypical Femur Fracture Risk versus Fragility Fracture Prevention with Bisphosphonates. (2020) (3)
- Bisphosphonates and atypical femoral fractures. (2010) (3)
- Osteoporosis in men. (2008) (3)
- New treatments for brittle bones. (2004) (3)
- A reappraisal of therapeutic approaches to osteoporosis. (2004) (3)
- Debating the duration of bisphosphonate therapy. (2013) (2)
- Review: Vitamin D with calcium reduces fractures in adults (2012) (2)
- Letter re: alendronate in anorexia nervosa. (2005) (2)
- In osteoporosis or osteopenia, exercise interventions improve BMD; effects vary by exercise type and BMD site (2022) (2)
- Bisphosphonates and BMU birth rate (2010) (2)
- What Are the Most Common Errors in the Management of Renal Osteodystrophy? (1989) (2)
- Serum markers of bone formation in parenteral nutrition patients (1990) (2)
- Discussion section III (1991) (2)
- PS2-28: The Association of Body Composition Indices and Hormonal Contraceptive Use in Adolescent and Young Adult Women (2012) (2)
- Low-dose thiazide and bone density. Authors' reply (2002) (2)
- Using Pharmacy Data and Adherence to Define Long-Term Bisphosphonate Exposure in Women. (2019) (2)
- Calculation of active formation period using label escape and three labels. (1992) (2)
- Faculty Opinions recommendation of Relation of serum serotonin levels to bone density and structural parameters in women. (2010) (1)
- Parathyroid hormone in aluminum bone disease (1986) (1)
- Determinants of Oral Bisphosphonate Use Beyond 5 Years. (2020) (1)
- Ten years of alendronate treatment for osteoporosis in postmenopausal women. (2004) (1)
- VERTEBRAL BONE MINERAL CONTENT MEASURED BY TWO TECHNIQUES OF COMPUTED TOMOGRAPHY AND COMPARED WITH DUAL PHOTON ABSORPTIOMETRY (1985) (1)
- In women, bisphosphonate use for ≥3 years vs. <3 months was linked to increased atypical femur fracture risk (2021) (1)
- Longitudinal Analysis of the Association Between Habitual Caffeine Intake and Bone Mineral Density Among Women Aged 14 to 40 (2006) (1)
- Renal insufficiency and bone loss. (2019) (1)
- Reply from Drs. Ott and Chesnut (1988) (1)
- PS2-29: Comparison of Self-reported Oral Contraceptive Use and Automated Prescription Fills (2012) (1)
- Does Estrogen Play a Role in Renal Osteodystrophy? (1995) (1)
- In postmenopausal women, oral but not transdermal estrogen was associated with increased risk for stroke (2016) (1)
- Bone Remodeling, Dynamics of (2004) (1)
- Physical therapy, chiropractic manipulation, or an educational booklet for back pain. (1999) (1)
- Screening for osteoporosis. (1990) (1)
- TOTAL BODY CALCIUM BY NEUTRON ACTIVATION ANALYSIS IN NORMALS AND IN OSTEOPOROTIC PATIENTS.: D1 (1983) (1)
- Faculty Opinions recommendation of Single-dose, placebo-controlled, randomized study of AMG 785, a sclerostin monoclonal antibody. (2010) (1)
- OR03-4 Atypical Femur Fracture Incidence Increases with Duration of Bisphosphonate Exposure (2019) (0)
- Osteoporosis Treatment: Not Easy (2023) (0)
- Book Review Vitamin D Edited by David Feldman, with Francis H. Glorieux and J. Wesley Pike. 1285 pp., illustrated. San Diego, Calif., Academic Press, 1997. $175. 0-12-252685-6 (1998) (0)
- Mineral changes in osteoporosis : A review : Osteoporosis (2006) (0)
- Alendronate in anorexia nervosa. Authors' reply (2005) (0)
- SIDELINE DECISIONS: CLOSE ENCOUNTERS WE HAVE SEEN FROM HEAD TO TOE (2002) (0)
- Chapter 12 – Special Concerns in the Female Athlete (2006) (0)
- Risk Factors for Musculoskeletal Symptoms in 5-20 Year Survivors Who Received Myeloablative Hematopoietic Cell Transplant (HCT) (2014) (0)
- Author's response (1988) (0)
- KDIGO clinical practice guidelines for bisphosphonate treatment in chronic kidney disease (2011) (0)
- Book Review Osteoporosis: Diagnostic and therapeutic principles (Current Clinical Practice.) Edited by Clifford J. Rosen. 297 pp., illustrated. Totowa, N.J., Humana Press, 1996. $99.50. 0-89603-374-0 (1996) (0)
- Faculty Opinions recommendation of Serum 25-hydroxyvitamin D and clinical fracture risk in a multiethnic cohort of women: the Women's Health Initiative (WHI). (2011) (0)
- To the editor [2] (2007) (0)
- LEG PAIN-FOOTBALL (2003) (0)
- KNEE INJURY-BASKETBALL (1999) (0)
- PS1-52: Charting the Course: Adjudicating Fractures in Network Enrollees Using the Electronic Medical Record (2012) (0)
- Faculty Opinions recommendation of 25-hydroxyvitamin D levels and the risk of mortality in the general population. (2008) (0)
- Treatment of Low Bone Density or Osteoporosis to Prevent Fractures in Men and Women (2017) (0)
- Consider the Bisphosphonate Dose (2021) (0)
- Factors That Influence Adult Bone Mass (2003) (0)
- Chapter 2 New aspects of normal bone biology (2010) (0)
- Faculty Opinions recommendation of Regulation of fibroblast growth factor-23 signaling by klotho. (2006) (0)
- Guideline: USPSTF recommends against menopausal estrogen for primary prevention of chronic conditions (2018) (0)
- Not etched in bone: the role of osteoclast proton-sensing receptors. (2021) (0)
- List of contributors (2021) (0)
- Structural and Metabolic Assessment of Bone. (2020) (0)
- after changing from casein to amino acids in parenteral solutions with reduced aluminum content14 (1988) (0)
- Management of Bone Disease in Candidates for Organ Transplant (2005) (0)
- Postmenopausal Osteoporosis. (2016) (0)
- Renal Osteodystrophy and Bone Biopsy (2020) (0)
- Making decisions about hormone replacement therapy [5] (multiple letters) (2003) (0)
- Faculty Opinions recommendation of Disease-associated mutations affect intracellular traffic and paracellular Mg2+ transport function of Claudin-16. (2006) (0)
- Low-dose thiazide and bone density [2] (multiple letters) (2002) (0)
- Low-Dose Thiazide and Bone Density (2002) (0)
- COMPARISON OF BONE MASS MEASUREMENTS IN OSTEOPOROSIS: CT, PHOTON ABSORPTIOMETRY, TOTAL BODY CALCIUM, PHOTODENSITOMETRY, AND BONE BIOPSY (1985) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Susan M. Ott?
Susan M. Ott is affiliated with the following schools:
